Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z160 in Postherpetic Neuralgia
NCT01757873Phase 2Completed
- Sponsor
- CombinatoRx
- Start
- Dec 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Z-160 in postherpetic neuralgia (PHN), sponsored by CombinatoRx. Started Dec 2012; status: completed.
02
Drugs
Z-160
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01757873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757873.